Pharmaceutical Product Development’s Senior Secured Credit Facilities
August 20, 2015
On August 18, 2015, Pharmaceutical Product Development, LLC (“PPD”), a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services, closed a dividend recapitalization transaction. Cravath represented Credit Suisse as lead arranger in connection with the arrangement of $2.875 billion of senior secured credit facilities. PPD is a portfolio company of The Carlye Group and Hellman & Friedman.
The Cravath team included partner Joseph D. Zavaglia and associates Matthew G. Jones and Sean M. Gholz. Summer associate Nathan H. Trunnell also worked on this matter.
Related Practices & Industries
People
- Photo
-
-
J.D., 2004, Brooklyn Law SchoolValedictorian, summa cum laude
-
B.B.A., 2001, College of Insurancecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
September 08, 2026
Valvoline Inc.’s Revolving Credit Facility and High‑Yield Senior Notes Offering
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with a $600 million revolving credit facility made available to Valvoline Inc., a leader in automotive preventive maintenance delivering convenient and trusted services in its retail stores throughout the United States and Canada. The transaction closed on August 24, 2026.
Deals & Cases
August 31, 2026
3M Company’s $4.25 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4.25 billion revolving credit facility made available to 3M Company, a leading diversified technology company. The transaction closed on August 17, 2026.
Deals & Cases
August 31, 2026
AdvanSix Inc.’s Credit Facilities
Cravath represented AdvanSix Inc. in connection with $425 million of credit facilities. AdvanSix Inc. is a leading integrated chemistry company that produces essential materials for diverse end markets. The facilities consisted of a $275 million revolving credit facility and a $150 million term loan facility. The transaction closed on August 14, 2026.
Deals & Cases
July 23, 2026
Nexeye’s Repricing of its Term Loan Facility
Cravath represented the arrangers in connection with the repricing of Nexeye Holding B.V.’s €325 million term loan facility. Nexeye Holding B.V., a portfolio company of KKR, is a leading European optical retailer. The transaction closed on June 9, 2026.
